People tired due to narcolepsy symptoms 3

“What effects were seen with XYREM in adult and pediatric studies?”

The efficacy and safety of XYREM have been established in clinical trials of adults and of pediatric patients ages 7-17 years who had narcolepsy.1

A double-blind, placebo-controlled, randomized-withdrawal, multicenter study evaluated XYREM for cataplexy and excessive daytime sleepiness (EDS) in pediatric narcolepsy.1,2

After the 2-week double-blind period, patients continued to receive XYREM treatment for a total study duration up to a year.1

4 clinical trials evaluated XYREM treatment for cataplexy or EDS in adult narcolepsy1

Two 4-week clinical trials explored XYREM for cataplexy in adults with narcolepsy.1

Two 8-week clinical trials evaluated XYREM for excessive daytime sleepiness (EDS) in adults with narcolepsy.1